These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 9071901

  • 1. Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck.
    Planting AS, de Mulder PH, de Graeff A, Verweij J.
    Eur J Cancer; 1997 Jan; 33(1):61-5. PubMed ID: 9071901
    [Abstract] [Full Text] [Related]

  • 2. Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group.
    Planting AS, Catimel G, de Mulder PH, de Graeff A, Höppener F, Verweij J, Oster W, Vermorken JB.
    Ann Oncol; 1999 Jun; 10(6):693-700. PubMed ID: 10442192
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
    Herchenhorn D, Dias FL, Viegas CM, Federico MH, Araújo CM, Small I, Bezerra M, Fontão K, Knust RE, Ferreira CG, Martins RG.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):696-702. PubMed ID: 20421154
    [Abstract] [Full Text] [Related]

  • 13. Conventional radiotherapy with concurrent weekly Cisplatin in locally advanced head and neck cancers of squamous cell origin - a single institution experience.
    Dimri K, Pandey AK, Trehan R, Rai B, Kumar A.
    Asian Pac J Cancer Prev; 2013 Nov 01; 14(11):6883-8. PubMed ID: 24377620
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA, Christen R, Los G, Jones V, Kerber C, Seagren S, Glassmeyer S, Orloff LA, Wong W, Kirmani S, Howell S.
    Otolaryngol Head Neck Surg; 1998 May 01; 118(5):597-602. PubMed ID: 9591856
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A.
    Otolaryngol Pol; 2011 Sep 01; 65(5 Suppl):117-25. PubMed ID: 22000261
    [Abstract] [Full Text] [Related]

  • 19. Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell cancer: a retrospective analysis of a tertiary institute experience.
    Osman N, Elamin YY, Rafee S, O'Brien C, Stassen LF, Timon C, Kinsella J, Brennan S, O'Byrne KJ.
    Eur Arch Otorhinolaryngol; 2014 Aug 01; 271(8):2253-9. PubMed ID: 24121822
    [Abstract] [Full Text] [Related]

  • 20. A phase I study of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex) in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck.
    ten Bokkel Huinink D, Tesselaar ME, Baatenburg de Jong RJ, Verschuur HP, Keizer HJ.
    Ann Oncol; 2001 Mar 01; 12(3):357-63. PubMed ID: 11332149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.